Abner Herrman & Brock’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26M | Sell |
202,424
-45
| -0% | -$5.27K | 2.47% | 13 |
|
|
2026
Q1 | $24.4M | Buy |
202,469
+4,155
| +2% | +$480K | 2.69% | 14 |
|
|
2025
Q4 | $20.9M | Buy |
198,314
+187,919
| +1,808% | +$17.6M | 2.13% | 20 |
|
|
2025
Q3 | $872K | Buy |
+10,395
| New | +$856K | 0.09% | 60 |
|
|
2025
Q1 | – | Sell |
-36,461
| Closed | -$3.63M | – | 55 |
|
|
2024
Q4 | $3.63M | Sell |
36,461
-98,749
| -73% | -$10.2M | 0.45% | 42 |
|
|
2024
Q3 | $15.4M | Buy |
135,210
+492
| +0.4% | +$58.5K | 1.85% | 26 |
|
|
2024
Q2 | $16.7M | Sell |
134,718
-3,831
| -3% | -$493K | 2.11% | 22 |
|
|
2024
Q1 | $18.3M | Sell |
138,549
-2,988
| -2% | -$368K | 2.28% | 21 |
|
|
2023
Q4 | $15.4M | Sell |
141,537
-2,521
| -2% | -$262K | 2.17% | 24 |
|
|
2023
Q3 | $14.8M | Sell |
144,058
-53,107
| -27% | -$5.72M | 2.27% | 23 |
|
|
2023
Q2 | $22.8M | Buy |
197,165
+47
| +0% | +$5.34K | 3.34% | 8 |
|
|
2023
Q1 | $21M | Sell |
197,118
-82
| -0% | -$8.85K | 3.17% | 8 |
|
|
2022
Q4 | $21.9M | Sell |
197,200
-887
| -0.4% | -$90.7K | 3.36% | 5 |
|
|
2022
Q3 | $17.1M | Buy |
198,087
+6,445
| +3% | +$575K | 3.13% | 10 |
|
|
2022
Q2 | $17.5M | Buy |
191,642
+1,808
| +1% | +$160K | 3.02% | 12 |
|
|
2022
Q1 | $15.6M | Buy |
+189,834
| New | +$15M | 2.19% | 23 |
|
|
2021
Q2 | – | Sell |
-201,273
| Closed | -$14.8M | – | 97 |
|
|
2021
Q1 | $14.8M | Sell |
201,273
-26,886
| -12% | -$1.98M | 2.24% | 19 |
|
|
2020
Q4 | $17.8M | Sell |
228,159
-17,589
| -7% | -$1.35M | 2.77% | 11 |
|
|
2020
Q3 | $19.5M | Sell |
245,748
-9,024
| -4% | -$707K | 3.28% | 8 |
|
|
2020
Q2 | $18.8M | Sell |
254,772
-16,943
| -6% | -$1.28M | 3.38% | 7 |
|
|
2020
Q1 | $19.9M | Sell |
271,715
-14,602
| -5% | -$1.15M | 4.52% | 3 |
|
|
2019
Q4 | $24.8M | Sell |
286,317
-24,942
| -8% | -$2.05M | 3.7% | 5 |
|
|
2019
Q3 | $25M | Sell |
311,259
-14,867
| -5% | -$1.19M | 3.69% | 5 |
|
|
2019
Q2 | $26.1M | Sell |
326,126
-3,468
| -1% | -$266K | 3.74% | 6 |
|
|
2019
Q1 | $26.2M | Buy |
329,594
+3,263
| +1% | +$244K | 4.03% | 4 |
|
|
2018
Q4 | $23.8M | Buy |
326,331
+45,066
| +16% | +$3.18M | 4.34% | 4 |
|
|
2018
Q3 | $19M | Buy |
281,265
+14,930
| +6% | +$951K | 2.72% | 9 |
|
|
2018
Q2 | $15.4M | Buy |
266,335
+10,386
| +4% | +$586K | 2.4% | 11 |
|
|
2018
Q1 | $13.3M | Buy |
255,949
+13,611
| +6% | +$735K | 2.11% | 14 |
|
|
2017
Q4 | $13M | Sell |
242,338
-26,785
| -10% | -$1.48M | 2.19% | 14 |
|
|
2017
Q3 | $16.4M | Buy |
269,123
+12,578
| +5% | +$763K | 2.91% | 7 |
|
|
2017
Q2 | $15.7M | Buy |
256,545
+2,593
| +1% | +$158K | 2.97% | 7 |
|
|
2017
Q1 | $15.4M | Sell |
253,952
-842
| -0.3% | -$51.1K | 3.06% | 4 |
|
|
2016
Q4 | $14.6M | Sell |
254,794
-32,150
| -11% | -$1.88M | 3.07% | 3 |
|
|
2016
Q3 | $17.1M | Buy |
286,944
+2,462
| +0.9% | +$144K | 3.88% | 1 |
|
|
2016
Q2 | $16.1M | Buy |
284,482
+6,065
| +2% | +$323K | 3.75% | 1 |
|
|
2016
Q1 | $14.1M | Buy |
278,417
+85,649
| +44% | +$4.19M | 3.53% | 1 |
|
|
2015
Q4 | $9.72M | Sell |
192,768
-4,873
| -2% | -$246K | 5.01% | 2 |
|
|
2015
Q3 | $9.61M | Buy |
197,641
+1,341
| +0.7% | +$71.2K | 5.13% | 1 |
|
|
2015
Q2 | $10.7M | Buy |
196,300
+4,223
| +2% | +$237K | 5.39% | 1 |
|
|
2015
Q1 | $10.5M | Buy |
192,077
+62
| +0% | +$3.51K | 5.36% | 1 |
|
|
2014
Q4 | $10.4M | Sell |
192,015
-86,379
| -31% | -$4.81M | 5.28% | 1 |
|
|
2014
Q3 | $15.7M | Buy |
278,394
+2,175
| +0.8% | +$122K | 4.63% | 1 |
|
|
2014
Q2 | $15.2M | Buy |
276,219
+10,674
| +4% | +$582K | 4.6% | 1 |
|
|
2014
Q1 | $14.4M | Buy |
265,545
+37,003
| +16% | +$1.92M | 4.61% | 1 |
|
|
2013
Q4 | $10.8M | Buy |
228,542
+153,060
| +203% | +$7M | 3.84% | 2 |
|
|
2013
Q3 | $3.43M | Sell |
75,482
-23,104
| -23% | -$1.05M | 2.28% | 14 |
|
|
2013
Q2 | $4.37M | Buy |
+98,586
| New | +$4.4M | 1.85% | 21 |
|
Other funds holding MRK
ATO
Abner Herrman & Brock's MRK Position: Q2 2026 in Review
Abner Herrman & Brock reduced its Merck (MRK) stake by 0.02% in Q2 2026, selling an estimated $5.27K and leaving 202,424 shares worth $26M. The position accounts for 2.47% of the portfolio, ranked #13.
Abner Herrman & Brock first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. The position peaked at $26.2M in Q1 2019. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Abner Herrman & Brock held 202,424 shares of Merck worth $26M as of Q2 2026.
- Abner Herrman & Brock sold 45 Merck shares in Q2 2026, an estimated $5.27K.
- Merck made up 2.47% of Abner Herrman & Brock's portfolio in Q2 2026, its #13 holding.
- Abner Herrman & Brock first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
- Abner Herrman & Brock's Merck position peaked at $26.2M in Q1 2019.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.